[ad_1]
Amid the threat of the deadly Coronavirus pandemic and so far without a specific antidote to it, Israel’s Defense Minister Naftali Bennett has claimed that his country has made significant progress towards treating the deadly virus.
The “monoclonal neutralizing antibody” developed at the Israel Biological Research Institute (IIBR) “can neutralize it [the disease-causing coronavirus] inside the bodies of the carriers, “Israel’s defense minister said in a statement.
Bennett visited the laboratories of the Israel Biological Research Institute (IIBR), a secret unit working under the Prime Minister’s Office, in Ness Ziona and was shown the “antibody that attacks the virus monoclonally and can neutralize it within bodies of the sick, “according to a statement from his office.
READ | India can easily synthesize new antiviral drug Remdesivir, says former ICMR director
READ | From plasma therapy to the administration of remdesivir; Doctors around the world urge caution
The antibody reported to have been isolated from IIBR is monoclonal, meaning that it was derived from a single recovered cell and therefore has a potentially more potent value for producing a treatment.
According to international media reports, IIBR Director Shmuel Shapira says the antibody formula was being patented, after which an international manufacturer would be sought to mass-produce it. On vaccine developments in other countries, coronavirus treatments have been developed from antibodies that are polyclonal or derived from two or more cells of different ancestry, the journal Science Direct reported in its May issue.
The small southern city of Yeruham has plans to open Israel’s first vaccine production facility, in association with the Israel Biological Research Institute (IIBR) and one of two possible international pharmaceutical companies, according to a spokesman for the local council of Yeruham.
READ | From plasma therapy to the administration of remdesivir; Doctors around the world urge caution
READ | ‘Significant step’: HHS chief approval praises Remdesivir’s emergency use for COVID-19
Israel was one of the first countries to close its borders and impose increasingly stringent restrictions on movements to hinder the outbreak of the domestic coronavirus. It has reported 16,246 cases and 235 deaths from the disease. As the world faces the Coronavirus that originated in China in December last year, countries have been competing against time to find a vaccine that can end the threat of the deadly virus.
Gilead Science’s Remdivisir is also touted as a possible cure for COVID-19. However, there is minimal data on it and better trials are needed as there are only a handful of trials conducted so far, according to reports. The United States government has given their hospitals permission to use Remdevisir to cure patients with COVID-19.
[ad_2]
